Millennium Management
FBLG icon

Millennium Management’s FibroBiologics FBLG Stock Holding History

Millennium Management’s Portfolio FBLG Stock Details FBLG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,425
Closed -$64.9K – 6489
2025
Q4 		$64.9K Sell
14,425
-7,885
-35% -$55.5K ﹤0.01% 5701
2025
Q3 		$244K Sell
22,310
-1,722
-7% -$20.6K ﹤0.01% 5450
2025
Q2 		$299K Buy
+24,032
New +$433K ﹤0.01% 5193
2024
Q4 		– Sell
-561
Closed -$34.7K – 6546
2024
Q3 		$34.7K Sell
561
-656
-54% -$43.6K ﹤0.01% 5733
2024
Q2 		$122K Sell
1,217
-9,245
-88% -$1.76M ﹤0.01% 5270
2024
Q1 		$2.26M Buy
+10,462
New +$2.52M ﹤0.01% 3623

Other funds holding FBLG

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FEG
Fund Evaluation Group Cincinnati, Ohio $3.7B AUM 16.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CFP
Cascade Financial Partners San Diego, California $1.15B AUM 33.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
Vanguard Global Advisers
Vanguard Global Advisers Malvern, Pennsylvania $215B AUM

Millennium Management's FBLG Position: Q1 2026 in Review

Millennium Management sold out of FibroBiologics (FBLG) in Q1 2026, closing a stake of 14,425 shares — an estimated $64.9K sold.

Millennium Management first reported a position in FBLG in Q1 2024 and held it in 6 quarters. The position peaked at $2.26M in Q1 2024. 17 funds tracked by Wall St. Rank hold FBLG as of Q1 2026.

  • Millennium Management reported no remaining FibroBiologics position as of Q1 2026 after selling out during the quarter.
  • Millennium Management sold 14,425 FibroBiologics shares in Q1 2026, an estimated $64.9K.
  • Millennium Management first reported a position in FibroBiologics in Q1 2024 and held it in 6 quarters.
  • Millennium Management's FibroBiologics position peaked at $2.26M in Q1 2024.
  • 17 funds tracked by Wall St. Rank held FibroBiologics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.